| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/02/1995 | US5412089 Antitumor, antiviral |
| 05/02/1995 | US5412072 Water soluble high molecular weight polymerized drug preparation |
| 05/02/1995 | US5411982 Cycloalkylene azoles, and their use as aromatase inhibitors |
| 05/02/1995 | US5411964 Phenylalanine-glycine compounds having anti-tumor activity, process for preparation thereof, and pharmaceutical composition containing said compounds |
| 05/02/1995 | US5411949 23-oxa-derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use pharmaceutical agents |
| 05/02/1995 | US5411947 converting drugs having suitable functional groups to 1-O-alkyl-, 1-O-acyl-, 1-S-acyl, and 1-S-alkyl-sn-glycero-3-phosphate derivatives; drugs such as AZT, cladribine, AICA-Riboside |
| 05/02/1995 | US5411943 Hepatoma treatment with somatostatin analogs |
| 05/02/1995 | CA1335452C Substituted tetralins, chromans and related compounds in the treatment of asthma |
| 04/30/1995 | CA2134194A1 Medicine for the treatment of tumor |
| 04/29/1995 | CA2134536A1 Cyclized analogues of fatty acid, process for their preparation and pharmaceutical compositions containing them |
| 04/29/1995 | CA2134418A1 Linear adhesion inhibitors |
| 04/27/1995 | WO1995011309A2 A novel nuclear mitotic phosphoprotein: mitosin |
| 04/27/1995 | WO1995011303A1 Cntf family antagonists |
| 04/27/1995 | WO1995011231A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | WO1995010938A1 Oligonucleotide modulation of multidrug resistance-associated protein |
| 04/27/1995 | CA2173978A1 A novel nuclear mitotic phosphoprotein: mitosin |
| 04/27/1995 | CA2173468A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/26/1995 | EP0649658A1 Method of tumor treatment |
| 04/26/1995 | EP0649650A1 Bioadhesive pharmaceutical composition for controlled release of drugs |
| 04/26/1995 | EP0649429A1 Heteroatomic oligonucleoside linkages |
| 04/26/1995 | EP0649413A1 Uracil derivatives as enzyme inhibitors |
| 04/26/1995 | EP0649411A1 Boronated compounds |
| 04/26/1995 | EP0649409A1 Vinyl arenas having retinoid-like activity |
| 04/26/1995 | EP0649405A1 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs. |
| 04/26/1995 | EP0649312A1 Anthracycline conjugates, their preparation and their use as antitumor agents |
| 04/26/1995 | EP0649302A1 Therapeutic and diagnostic use of modified polymeric microcapsules |
| 04/26/1995 | EP0572437B1 2,4-diaminoquinazolines derivatives for enhancing antitumor activity |
| 04/26/1995 | EP0486565B1 Discodermolide compounds, compositions containing same and methods of preparation and use |
| 04/26/1995 | EP0482076B1 Stable vaccine compositions containing interleukins |
| 04/26/1995 | EP0451190B1 Deletion analogues of magainin peptides |
| 04/26/1995 | EP0436642B1 Pre-activated therapeutic agents derived from photoactive compounds |
| 04/26/1995 | CN1101915A New 19-nor steroids having a phenoxyalkylsulphonamide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical compositions.. |
| 04/25/1995 | US5410080 Treating breast cancer |
| 04/25/1995 | US5410036 1',6,6'-triamino- and 6,6'-diamino- sucrose derivatives |
| 04/25/1995 | US5410024 Cellular antigrowth agent |
| 04/25/1995 | US5409953 Isolation, structural elucidation and synthesis of novel antineoplastic substances denominated "combretastatins" |
| 04/25/1995 | US5409952 Heterocyclic compounds: 2-styryl-4H-1-benzopyran-4-ones |
| 04/25/1995 | US5409949 Methylen-oxindole derivatives compositions and tyrosine kinase inhibition therewith |
| 04/25/1995 | US5409930 Inhibits abnoramal cell proliferation; dimethoxyquinoline/ dimethylquinoline/ quinolineoxide/ and quinoxaline derivatives |
| 04/25/1995 | US5409698 Liposome immunoadjuvants containing IL-2 |
| 04/25/1995 | CA1335379C Aralkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same |
| 04/25/1995 | CA1335378C Alkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same |
| 04/20/1995 | WO1995010630A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | WO1995010539A1 Growth differentiation factor-10 |
| 04/20/1995 | WO1995010516A1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 04/20/1995 | WO1995010515A1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 04/20/1995 | WO1995010514A1 Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 04/20/1995 | WO1995010307A1 Radiation sensitization using texaphyrins |
| 04/20/1995 | WO1995010305A1 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes |
| 04/20/1995 | WO1995010296A1 A library of glyco-peptides useful for identification of cell adhesion inhibitors |
| 04/20/1995 | WO1995010293A1 Compounds for medicinal use |
| 04/20/1995 | WO1995010286A1 Inhibitors of phosphoinositide-specific phospholipase c |
| 04/20/1995 | WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/1995 | CA2174136A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | CA2173990A1 A library of glyco-peptides useful for identification of cell adhesion inhibitors |
| 04/20/1995 | CA2173456A1 Inhibitors of phosphoinositide-specific phospholipase c |
| 04/20/1995 | CA2173322A1 Compounds for medicinal use |
| 04/20/1995 | CA2171546A1 Growth differentiation factor-10 |
| 04/19/1995 | EP0648779A2 New 11-benzaldehyde oxime, 17-beta methoxy, 17 alpha methoxymethyl derivates of estradiene, a process for their preparation and pharmaceutical compositions containing them |
| 04/19/1995 | EP0648778A2 11-Benzaldoximeestradiene-derivates, a process for their preparation and pharmaceutical compositions containing them |
| 04/19/1995 | EP0648493A1 A method to reverse the phenotype of transformed cells by the transcription factor IRF-1 |
| 04/19/1995 | EP0648492A2 Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof |
| 04/19/1995 | EP0648276A1 Monoclonal antibodies to glycoprotein p |
| 04/19/1995 | EP0648254A1 Luminescent article with high phosphor to binder ratio and manufacture thereof. |
| 04/19/1995 | EP0648223A1 Substituted lactose derivatives as cell adhesion inhibitors |
| 04/19/1995 | EP0648217A1 Novel sucrose ligands, methods for their preparation, platinum complexes derived therefrom, and methods for their usage |
| 04/19/1995 | EP0648206A1 Peptidyl derivatives and their use as metalloproteinase inhibitors |
| 04/19/1995 | EP0648205A1 Peptidyl derivatives as metalloproteinase inhibitors |
| 04/19/1995 | EP0648126A1 Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma, stomach cancer and breast cancer |
| 04/19/1995 | EP0624096A4 Taxol as a radiation sensitizer. |
| 04/19/1995 | EP0451299B1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier |
| 04/19/1995 | CN1101572A Tumor metastasis-suppressing agent and veterinary tumor metastasis-suppressing agent |
| 04/19/1995 | CN1101559A Traditional Chinese medicine oral administration liquid for anti-cancer and its preparing method |
| 04/18/1995 | US5407952 Azole derivatives, pharmaceutical compositions containing the same, and method for treating mycosis and estrogen-dependent diseases |
| 04/18/1995 | US5407940 New ellipticine compounds |
| 04/18/1995 | US5407939 Fluorinated 17 β-substituted 4-aza-5 α-androstan-3-one derivatives |
| 04/18/1995 | US5407925 Administering a cytolytic, pre-activated, bifunctional alkylating agent; antitumor agents |
| 04/18/1995 | US5407912 Method of treating bladder cancer with a keyhole limpet hemocyanin composition with enhanced anti-tumor activity |
| 04/18/1995 | US5407805 Monoclonal antibody reactive to various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment |
| 04/18/1995 | US5407674 Plant extracts |
| 04/18/1995 | CA1335268C Methods of technetium/rhenium labeling of proteins |
| 04/16/1995 | CA2118097A1 Methods for inhibiting angiogenesis and angiogenic diseases |
| 04/16/1995 | CA2118096A1 Methods for treating resistant neoplasms |
| 04/13/1995 | WO1995009912A1 Stem cell proliferation factor |
| 04/13/1995 | WO1995009871A1 Novel antitumor peptide |
| 04/13/1995 | WO1995009866A1 Glutathione s-transferase-activated compounds |
| 04/13/1995 | WO1995009865A1 Glutathione s-transferase-activated compounds |
| 04/13/1995 | WO1995009856A1 Boronated metalloporphyrins and therapeutic methods |
| 04/13/1995 | WO1995009853A1 Pharmacologically active pyridine derivatives and processes for the preparation thereof |
| 04/13/1995 | WO1995009852A1 Further pyrimidine derivatives and their preparation |
| 04/13/1995 | WO1995009851A1 Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
| 04/13/1995 | WO1995009845A1 Pyrimidinyl-glutamic acid derivatives |
| 04/13/1995 | WO1995009841A1 Hydroxamic acid derivatives as inhibitors of cytokine production |
| 04/13/1995 | WO1995009656A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | WO1995009655A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 04/13/1995 | WO1995009654A1 Gene therapy of the nervous system |
| 04/13/1995 | WO1995009637A1 Highly sulfated maltooligosaccharides with heparin-like properties |
| 04/13/1995 | WO1995009626A1 Mycophenolate mofetil high dose oral suspensions |
| 04/13/1995 | WO1995007934A3 Il8 inhibitors |
| 04/13/1995 | WO1995007718A3 Purine nucleoside phosphorylase gene therapy for human malignancy |